Prostate Cancer Project
Prostate cancer is the second most common cancer diagnosed in the United States after Breast Cancer, and it is one of the most common types of cancer in men. About 1 man in 9 will be diagnosed with prostate cancer during his lifetime, and it is estimated that almost 35,000 American men died of it in 2021.
Prostate cancer represents 5.6% of cancer deaths. It is more likely to develop in older men and in African-American men. About 6 cases in 10 are diagnosed in men who are 65 or older, and it is rare in men under 40.
While the majority of men diagnosed with prostate cancer will live a long time, challenges remain in choosing the best treatments for individuals at all stages of the disease. The National Cancer Center Prostate Cancer Project was inaugurated in 2020 to fund innovative researchers who are working to advance our understanding of how to prevent, detect, and treat prostate cancer. Prostate cancer research funding is badly needed to fuel the progress we have already made which will enhance finding a cure.
Current Grants and Renewals
National Cancer Center has been proud to award grants to many fine research organizations.
We know that a cure lies in research and we are committed to supporting as many research projects as we can.
Chitra Rawat, Ph.D.
Cleveland Clinic, Cleveland OH PROJECT: Elucidating the role of CIT-Mediated phosphorylation on pre-mRNA splicing in prostate cancer
TYPE: NEW GRANT
Gaurav Chauhan, Ph.D.
Cleveland Clinic, Cleveland OH
PROJECT: Deciphering the role for PKN1-SRF signaling in deregulated gene expression and splicing events in treatment-resistant prostate cancer
TYPE: RENEWAL
Past Beneficiaries
Varadha Belaji Venkadakrishnan, Ph.D.
Dana-Farber Cancer Institute, Boston, MA
PROJECT: Collaboration between EZH2 and DNA methyltransferase to drive lineage programming in advanced prostate cancer
2021-2023
